Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Pharmorphix Logo
Pharmorphix Growth Score
79
CB Rank
3550724
Heat Score
52
Pharmorphix is a leading provider of solid form research services to the pharmaceutical, biotechnology and speciality chemical industries.
Acquired by
Johnson Matthey Logo
Johnson Matthey
Founded
obfuscation
Private
Biotechnology
Health Care
Pharmaceutical
Overview

Pharmorphix
Growth Score
79
Heat Score
52

Growth Score79
-7 pts
in past quarter
Heat Score 52
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Pharmorphix

CB Rank
3550724
Pharmorphix is a leading provider of solid form research services to the pharmaceutical, biotechnology and speciality chemical industries.
Acquired by
Johnson Matthey Logo
Johnson Matthey
Founded
obfuscation
Private
Biotechnology
Health Care
Pharmaceutical

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

Pharmorphix was acquired by Johnson Matthey on
obfuscation
.
Transaction Name 
Pharmorphix acquired by Johnson Matthey Logo
Pharmorphix acquired by Johnson Matthey
Acquired by 
Johnson Matthey Logo
Johnson Matthey
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
News
Technology
View Tech Report

IT Spend

$545.2MThis year, Pharmorphix is projected to spend $545.2M on IT, according to Aberdeen.
Sub-Organizations
Frequently Asked Questions
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|